Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the effica...
Study of Psilocybin for Anorexia in Young Adults
This is a single site trial of psilocybin therapy for the treatment of refractory Anorexia Nervosa in young adults. The psilocybin therapy will include three preparatory sessions, psilocybin dosing se...
Top Cities for Eating Disorders Clinical Trials
Eating Disorders clinical trials are recruiting across 11 cities. Here are the cities with the most active studies:
About Eating Disorders
Eating disorders are serious mental health conditions involving unhealthy relationships with food, weight, and body image. Types include anorexia nervosa, bulimia nervosa, and binge eating disorder. Treatment involves psychotherapy, nutritional counseling, and medical monitoring.
Clinical trials are advancing new treatments for eating disorders. Currently, 2 studies are recruiting a combined 490 participants across the United States. Research is being conducted by 2 organizations including Axsome Therapeutics, Inc., Marissa Raymond-Flesch, MD, MPH.
2026 Eating Disorders Research Landscape
As of March 2026, the eating disorders clinical trial landscape includes 2 actively recruiting studies across 11 cities in the United States. These studies are collectively seeking 490 participants, with an average enrollment target of 245 per study.
Research is being led by 2 different organizations, including Axsome Therapeutics, Inc., Marissa Raymond-Flesch, MD, MPH.
Geographically, eating disorders trials are most concentrated in San Francisco, California (2 trials); Encino, California (1 trial); Garden Grove, California (1 trial); Long Beach, California (1 trial); Newport Beach, California (1 trial) and 6 other cities.
Featured Eating Disorders Studies
Highlighted recruiting studies for eating disorders, selected by enrollment size and research scope.
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
Study of Psilocybin for Anorexia in Young Adults
This is a single site trial of psilocybin therapy for the treatment of refractory Anorexia Nervosa in young adults. The psilocybin therapy will include three preparatory sessions, psilocybin dosing session one (20mg), two integration sessions, psilocybin dosing session two (up to 30mg), and four final integration sessions. Eating disorder symptoms will be measured pre and post treatment. Two famil...
Frequently Asked Questions About Eating Disorders Clinical Trials
Are there eating disorders clinical trials near me?
Yes, there are 2 eating disorders clinical trials currently recruiting across 11+ cities in the United States, including San Francisco, California; Encino, California; Garden Grove, California. Browse the studies above to find one at a location convenient for you.
How do I join a eating disorders clinical trial?
To join a eating disorders clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are eating disorders clinical trials free?
Yes, participation in eating disorders clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of eating disorders treatments are being studied?
Current eating disorders clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in eating disorders clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov